Morphologic, Hemostasiologic and Hemostatic Aspects of Systemic Application of Exogenous Fibrin Monomer in Model of Posttraumatic Bleeding with Underlying Intake of Warfarin

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

INTRODUCTION: Earlier, an ability of exogenous fibrin monomer (FM) introduced at low doses to considerably limit posttraumatic blood loss was established by us on an experimental model of warfarin coagulopathy in vivo. However, the morphologic peculiarities of fibrin formation in the wound area were not considered.

AIM: To compare morphologic, hemostasiologic and hemostatic data based on the results of systemic application of exogenous FM to interpret their effects in the model of posttraumatic bleeding with the underlying intake of warfarin.

MATERIALS AND METHODS: In the work, Chinchilla male rabbits were used. A comparative analysis of hemostasiologic effects and of morphologic picture of the surface of the liver in the wound area was conducted after a dosed trauma, with a preliminary systemic introduction of FM (0.25 mg/kg intravenously) or a concentrate of prothrombin complex factors (40 IU/kg intravenously) with the underlying intake of warfarin by animals (0.4–0.5 mg/kg/day per os for 2 weeks).

RESULTS: Introduction of FM in warfarinised animals in the conditions of a dosed experimental liver injury promoted a hemostatic effect comparable with that of a concentrate of prothrombin complex factors. Both hemostatic drugs led to intense fibrin formation that reduced posttraumatic blood loss. The use of FM was associated with increase in the thickness of thrombotic deposits and fibrin fibers in the wound surface in comparison with placebo by 4.0 and 1.6 times, respectively (р < 0.000001). This process actively involved platelets, which led to 1.7 times reduction of their quantity in the lumen of the blood vessels in the wound vicinity (р < 0.0002). No effect of FM on systemic hemostatic reactions in venous blood was found, in contrast to concentrate of prothrombin complex factors.

CONCLUSION: Exogenous FM can produce a local hemostatic effect in the conditions of dosed experimental trauma and coagulopathy induced by warfarin intake. The hemostatic effect was mediated by intense thrombosis on the wound surface with the active recruitment of platelets in the process. The peculiarities of the demonstrated effects of FM may be mediated though the mechanisms of its action that have not yet been identified, which necessitates continuation of the research in this direction.

About the authors

Vyacheslav M. Vdovin

Altay State Medical University

Author for correspondence.
Email: erytrab@gmail.com
ORCID iD: 0000-0002-4606-3627
SPIN-code: 5885-4504
ResearcherId: B-4400-2019

MD, Cand. Sci. (Med.), Associate Professor

Russian Federation, Barnaul

Igor' I. Shakhmatov

Altay State Medical University

Email: iish59@yandex.ru
ORCID iD: 0000-0002-0979-8560
SPIN-code: 1574-4980
ResearcherId: B-4629-2019

MD, Dr. Sci. (Med.), Professor

Russian Federation, Barnaul

Igor' P. Bobrov

Altay State Medical University

Email: ig.bobrov2010@yandex.ru
ORCID iD: 0000-0001-9097-6733
SPIN-code: 2375-1427
ResearcherId: CAJ-4653-2022

MD, Dr. Sci. (Med.)

Russian Federation, Barnaul

Dmitriy A. Orekhov

Altay Regional Cardiology Dispensary

Email: orekhoffs@mail.ru
ORCID iD: 0000-0003-0644-6313
SPIN-code: 5301-3553
Russian Federation, Barnaul

Vyacheslav V. Teryayev

Altay State Medical University

Email: teryaevw@yandex.ru
ORCID iD: 0000-0001-5968-3246
SPIN-code: 7117-6858
ResearcherId: CTX-3550-2022
Russian Federation, Barnaul

Vladimir E. Chernus'

Altay State Medical University

Email: chernus97@mail.ru
ORCID iD: 0000-0003-0800-4906
Russian Federation, Barnaul

Andrey P. Momot

Altay State Medical University; Altay Branch of the National Medical Research Center for Hematology

Email: xyzan@yandex.ru
ORCID iD: 0000-0002-8413-5484
SPIN-code: 8464-9030
ResearcherId: M-7923-2015

MD, Dr. Sci. (Med.), Professor

Russian Federation, Barnaul; Barnaul

References

  1. Weisel JW, Litvinov RI. Red blood cells: the forgotten player in hemostasis and thrombosis. Journal of Thrombosis and Haemostasis. 2019;17(2):271–82. doi: 10.1111/jth.14360
  2. Schastlivtsev IV, Lobastov KV, Tsaplin SN, et al. Modern view on hemostasis system: cell theory. Medical Council. 2019;(16):72–7. (In Russ). doi: 10.21518/2079-701X-2019-16-72-77
  3. Podoplelova NA, Sulimov VB, Tashilova AS, et al. Blood coagulation in the 21st century: existing knowledge, current strategies for treatment and perspective. Pediatric Hematology/Oncology and Immunopathology. 2020;19(1):139–57. (In Russ). doi: 10.24287/1726-1708-2020-19-1-139-157
  4. Mangin PH, Neeves KB, Lam WA, et al. In vitro flow-based assay: from simple toward more aophisticated models for mimicking hemostasis and thrombosis. Journal of Thrombosis and Haemostasis. 2021;19(2):582–7. doi: 10.1111/jth.15143
  5. Lugovskoy EV, Makogonenko EM, Komisarenko SV. Molecular mechanisms of formation and degradation of fibrin: Physical, chemical and immunochemical analysis. Kiev: Naukova dumka; 2013. (In Russ).
  6. Weisel JW, Litvinov RI. Fibrin formation, structure, and properties. In: Parry D.A.D. & Squire J.M., editors. Fibrous Proteins: Structures and Mechanisms. Pt: Subcellular Biochemistry. 2017;82:405–56. doi: 10.1007/978-3-319-49674-0_13
  7. Momot AP, Vdovin VM, Orekhov DA, et al. Effect of an exogenous fibrin monomer on hemostatic potential and fibrin formation in the area of controlled liver injury on the background of heparin administration in experiment. Pathogenesis. 2020;18(4):32–42. (In Russ). doi: 10.25557/2310-0435.2020.04.32-42
  8. Vdovin VM, Momot AP, Krasyukova VO, et al. Systemic Hemostatic and Hemostasiological Effects of Fibrin Monomer in Direct Thrombin Inhibition in Experiment. Russian Journal of Physiology. 2019;105(2):207–15. (In Russ). doi: 10.1134/S0869813919020109
  9. Vdovin VM, Momot AP, Shakhmatov II, et al. Effects of tranexamic acid and exogenous fibrin monomer on the liver injury area and systemic circulation in pharmacological suppression of platelet function in an experiment. Kazan Medical Journal. 2021;102(5):642–53. (In Russ). doi: 10.17816/KMJ2021-642
  10. Park K–J, Kwon E–H, Kim H–J, et al. Evaluation of the Diagnostic Performance of Fibrin Monomer in Disseminated Intravascular Coagulation. The Korean Journal of Laboratory Medicine. 2011;31(3):143–7. doi: 10.3343/kjlm.2011.31.3.143
  11. Vdovin VM, Momot AP, Orehov DA, et al. Systemic hemostatic and hemostasiological effects of fibrin monomer in low dose under warfarin action in experiment. Tromboz, Gemostaz i Reologiya. 2019;79(3):16–23. (In Russ). doi: 10.25555/THR.2019.3.0885
  12. Mironov AN, editor. Rukovodstvo po provedeniyu doklinicheskikh issledovaniy lekarstvennykh sredstv. Pt. 1. Moscow: Grif i K; 2012. (In Russ).
  13. Papayan LP, Golovina OG, Chechetkin AV, et al. Algoritm diagnostiki gemostaza i monitoring antitromboticheskoy terapii. Saint-Petersburg; 2016. (In Russ).
  14. Zerbino DD, Lukasevich LL. Disseminirovannoye vnutrisosudistoye svertyvaniye krovi: Fakty i kontseptsii. Moscow: Meditsina; 1989. (In Russ).
  15. Vdovin VM, Momot AP, Orekhov DA, et al. Influence of Exogenous Fibrin Monomer on Hemostatic Potential and Formation of Fibrin in the Area of Dosed Liver Injury in Experiment. Russian Journal of Physiology. 2020;106(9):1132–1143. (In Russ). doi: 10.31857/S0869813920070092
  16. Collet JP, Park D, Lesty C, et al. Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20(5):1354–61. doi: 10.1161/01.atv.20.5.1354
  17. Wolberg AS. Thrombin generation and fibrin clot structure. Blood Reviews. 2007;21(3):131–42. doi: 10.1016/j.blre.2006.11.001
  18. Reimers RC, Sutera SP, Joist JH. Potentiation by red blood cells of shear-induced platelet aggregation: relative importance of chemical and physical mechanisms. Blood. 1984;64(6):1200–06.
  19. Goel MS, Diamond SL. Adhesion of normal erythrocytes at depressed venous shear rates to activated neutrophils, activated platelets, and fibrin polymerized from plasma. Blood. 2002;100(10):3797–803. doi: 10.1182/blood-2002-03-0712
  20. Whelihan MF, Lim MY, Mooberry MJ, et al. Thrombin generation and cell-dependent hypercoagulability in sickle cell disease. Journal of Thrombosis and Haemostasis. 2016;14(10):1941–52. doi: 10.1111/jth.13416

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Morphologic changes in the liver wound area after spontaneous stoppage of bleeding on an example of a rabbit from the placebo group: A — thrombotic masses, hematoxylin and eosin stain, × 100 magnification; B — fibrin fibers (arrows) in thrombotic masses, MSB stain for fibrin, × 400 magnification; C — lumen of large vessels in the wound area containing platelets (arrows), hematoxylin and eosin stain, × 1000 magnification.

Download (100KB)
3. Fig. 2. Morphologic changes in the liver wound area after spontaneous stoppage of bleeding on an example of a rabbit from warfarin plus placebo group: A — thrombotic masses, hematoxylin and eosin stain, × 100 magnification; B — fibrin fibers (arrows) in thrombotic masses, MSB stain for fibrin, × 400 magnification; C — lumen of large vessels in the wound area containing platelets (arrows), hematoxylin and eosin stain, × 1000 magnification.

Download (111KB)
4. Fig. 3. Morphologic changes in the liver wound area after spontaneous stoppage of bleeding on an example of a rabbit from warfarin plus CPCF group: A — thrombotic masses, hematoxylin and eosin stain, × 100 magnification; B — fibrin fibers (arrows) in thrombotic masses, MSB stain for fibrin, × 400 magnification; C — lumen of large vessels in the wound area containing platelets (arrows), hematoxylin and eosin stain, × 1000 magnification.

Download (102KB)
5. Fig. 4. Morphologic changes in the liver wound area after spontaneous stoppage of bleeding on an example of a rabbit from warfarin plus FM group: A — thrombotic masses, hematoxylin and eosin stain, × 100 magnification; B — fibrin fibers (arrows) in thrombotic masses, MSB stain for fibrin, × 400 magnification; C — lumen of large vessels in the wound area containing platelets (arrows), hematoxylin and eosin stain, × 1000 magnification.

Download (103KB)

Copyright (c) 2023 Vdovin V.M., Shakhmatov I.I., Bobrov I.P., Orekhov D.A., Teryayev V.V., Chernus' V.E., Momot A.P.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies